Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP sequencing analysis of HA-JICD overexpressed Ink4a-/- murine astrocytes

ABSTRACT: This study demonstrate the biological function of JAG1 intracellular domain (JICD1). In order to elucidate the transcriptional regulation of JICD1, ChIP sequencing were performed using HA and H3K9Ac antibody.

ORGANISM(S): Mus musculus

PROVIDER: GSE126854 | GEO | 2021/02/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA sequencing analysis of HA-JICD1 and NICD1 overexpressed Ink4a-/- murine astrocytes [RNA-seq]

Project description:This study demonstrate the biological function of JAG1 intracellular domain (JICD1). In order to elucidate the characteristics of JICD1, HA-JICD1 and NICD1 overexpressed in murine Ink4a-/- astrocytes.

2021-02-01 | GSE126853 | GEO

ChIP sequencing analysis of HA-JICD overexpressed Ink4a-/- murine astrocytes

Project description:ChIP sequencing analysis of HA-JICD overexpressed Ink4a-/- murine astrocytes

| PRJNA523529 | ENA

RNA sequencing analysis of HA-JICD1 and NICD1 overexpressed Ink4a-/- murine astrocytes [RNA-seq]

Project description:RNA sequencing analysis of HA-JICD1 and NICD1 overexpressed Ink4a-/- murine astrocytes [RNA-seq]

| PRJNA523530 | ENA

RNA-seq and ChIP-seq analysis of HA-JICD1 and NICD1 overexpressed Ink4a-/- murine astrocytes

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-02-01 | GSE126855 | GEO

RNA-seq and ChIP-seq analysis of HA-JICD1 and NICD1 overexpressed Ink4a-/- murine astrocytes

Project description:RNA-seq and ChIP-seq analysis of HA-JICD1 and NICD1 overexpressed Ink4a-/- murine astrocytes

| PRJNA523527 | ENA

Acinetobacter sp. HA strain:HA

Project description:Acinetobacter sp. HA strain:HA Genome sequencing and assembly

| PRJNA158435 | ENA

Labyrinthula sp. Ha isolate:Ha

Project description:Labyrinthula sp. Ha isolate:Ha Genome sequencing and assembly

| PRJNA607370 | ENA

miRNA array in the A549 Ago2-KO/HA-Ago2Wt, Ago2-KO/HA-Ago2KA, and Ago2-KO/HA-Ago2Δ (Dm) cells

Project description:We used miRNA microarrays to detail the miRNA content in A549 Ago2-KO/HA-Ago2Wt, Ago2-KO/HA-Ago2KA, and Ago2-KO/HA-Ago2Δ (Dm) cells

2024-04-18 | GSE255941 | GEO

HA-TFE3 bound regions in HK-2 HA-TFE3-inducible cells

Project description:TFE3 is a bHLH-ZIP transcription factor, which nuclear localization is regulated by a tumor suppressor FLCN. In order to analyze TFE3 occupancy in whole genome, we have generated and utilized a HK-2 HA-TFE3-inducible cell line which express HA-tagged TFE3 in a doxycycline-dependent manner. HA-TFE3 bound regions were determined by ChIPSeq.

2020-08-07 | GSE135490 | GEO

Trial of FOLF(HA)Iri With Cetuximab in mCRC

Project description:As an approach to improve efficacy and provide clinical benefit to cancer patients undergoing chemotherapeutic treatment regimens, Alchemia Oncology has developed a novel means for delivering anti-cancer agents to tumours. The drug delivery platform is based on the use of hyaluronic acid (HA), a novel excipient, in which, formulation with HA results in optimisation of cytotoxic drug uptake and retention within solid tumours. In the specific example of HA-Irinotecan, this new formulation of irinotecan has demonstrated enhanced efficacy in both nonclinical and early clinical studies. The current study is an investigation into the use of HA-Irinotecan in a Phase II single arm trial of FOLF(HA)iri plus cetuximab in irinotecan-naïve second line patients with KRAS wild type metastatic colorectal cancer. The study objectives are to confirm the safety and efficacy of FOLF(HA)iri plus cetuximab as second-line therapy in irinotecan-naïve metastatic colorectal cancer patients. It is expected that the study recruit approximately 40-50 patients in 1 year with subsequent treatment and follow up; thus the trial will run for approximately 2-3 years.

| 2172573 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data